Becton Dickinson and Company (BDX)

NYSE
Currency in USD
Disclaimer
241.12
-0.65
(-0.27%)
Closed
241.12
0.00
(0.00%)
After Hours
Real-time Data
Day's Range
240.64
243.32
52 wk Range
215.90
269.06
Volume
819,747
Prev. Close
241.77
Open
241.58
Day's Range
240.64-243.32
52 wk Range
215.9-269.06
Volume
819,747
Average Volume (3m)
1,044,654
1-Year Change
-5.98%
Shares Outstanding
284,014,905
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
287.42
Upside +19.20%

People Also Watch

190.09
CB
-0.26%
229.14
SHW
+1.16%
272.58
SYK
+0.07%

Becton Dickinson and Company News

Becton Dickinson and Company Analysis

Becton Dickinson and Company Company Profile

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.